Tag Archives: FluoroPharma

MissionIR News – FluoroPharma Medical First in Class Diagnostic Agent Advanced to Phase II Study

Posted on March 8, 2012 by jamesmsanchez

Atlanta, GA (PRWEB) March 02, 2012 MissionIR would like to highlight FluoroPharma (OTCBB: FPMI), a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products to evaluate disease at the cellular and molecular levels. The company has … Continue reading →

Posted in Reputation | Tagged , , , , , , , , , , | Leave a comment